Off-label drug use in children over the past decade: a scoping review  

作　　者：Yuyi Tang Weiguo Li Jing Liao Xiaoqing Wang Muna Baskota Enmei Liu 

机构地区：[1]Department of Respiratory Medicine,Children’s Hospital of Chongqing Medical University,Chongqing 400014,China [2]National Clinical Research Center for Child Health and Disorders,Ministry of Education Key Laboratory of Child Development and Disorders,China International Science and Technology Cooperation Base of Child Development and Critical Disorders,Children’s Hospital of Chongqing Medical University,Chongqing 400014,China [3]Chongqing Key Laboratory of Pediatrics,Chongqing 400014,China.

出　　处：《Chinese Medical Journal》2023年第5期626-628,共3页中华医学杂志（英文版）

摘　　要：To the Editor:Off-label drug use(OLDU)refers to the use of a drug outside of the age,indication,weight,dose,formulation,or route of administration indicated on the label.It is a major concern and a common practice for clinicians around the globe,especially for pediatricians,owing to the lack of pediatric-specific drug information.[1]Research showed that US office-based physicians had ordered 41.2 million off-label orders per year for children and the trend had been increasing from 2006 to 2015.

关 键 词：DRUG PEDIATRIC OUTSIDE 

分 类 号：R95[医药卫生—药学]